HCW Biologics Inc. (HCWB) insider trading.
In Q3 2026, insiders at HCW Biologics Inc. reported 3 non-derivative transactions on 3 Forms 3, 4 and 5: 3 open-market purchases worth $100K and 0 sales.
- Transactions
- 3
- Purchases (P)
- 3
- Sales (S)
- 0
- Net shares, P minus S
- 38,682
- Insiders
- 3
- Last filed
- 2026-07-31
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Garrett Scott T | Director | 1 | 1 | 0 |
| Flowers Lee | Officer · SVP of Business Development | 1 | 1 | 0 |
| Wong Hing C | Director, Officer, TenPercentOwner · Chief Executive Officer | 1 | 1 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-29 | Garrett Scott T | P (A) | 7,736 | $2.59 | 41,644 | Form 4 |
| 2026-07-29 | Flowers Lee | P (A) | 7,736 | $2.59 | 8,691 | Form 4 |
| 2026-07-29 | Wong Hing C | P (A) | 23,210 | $2.59 | 125,845 | Form 4 |
Transaction codes in this quarter
Get HCWB insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1828673&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · HCWB company page · HCW Biologics Inc. on SEC.gov
Questions
Are insiders buying or selling HCW Biologics Inc. (HCWB)?
In Q3 2026, insiders at HCW Biologics Inc. reported 3 non-derivative transactions on 3 Forms 3, 4 and 5: 3 open-market purchases worth $100K and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these HCW Biologics Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/hcwb.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.